Alamar Biosciences, Inc.
ALMR
NASDAQ·Healthcare·Biotechnology·Mkt cap $2.1B
$30.80
▲ +0.75%
P/E
-31.75
Mkt Cap
$2.1B
52-Wk Range
$18.85–$38.54
52-Week Range
$18.85 - $38.54
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 40.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta -6.2).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Hot
+60.3% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying ALMR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 10, 2026
Reported EPS of -$0.22 vs -$0.31 consensus (+28.5% surprise). Revenue of $29.4M vs $25.9M expected (+13.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+28.5%
Revenue trend · last 2Q
—
—
Q1 26
Q2 26
$26.0M
$29.4M
Margins · last 2Q
Gross
60.2%
Operating
-46.0%
Profit
-44.9%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: TD Cowen · Jul 15, 2026
vs Industry
How ALMR stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.